Objectives: In treating critical limb ischemia (CLI), bypass grafting to tibial or paramalleolar arteries plays pivotal role. Though the graft flow (GF) differs significantly among patients, the factors associated with GF are not well studied. Herein, we assessed the factors and developed the predictive equation of GF in tibial or paramalleolar bypass grafting.
Objectives: In treating critical limb ischemia (CLI), bypass grafting to tibial or paramalleolar arteries plays pivotal role. Though the graft flow (GF) differs significantly among patients, the factors associated with GF are not well studied. Herein, we assessed the factors and developed the predictive equation of GF in tibial or paramalleolar bypass grafting.
Methods: CLI patients treated in our institution from January 2012 to November 2016, with bypass to tibial or paramalleolar arteries, were enrolled. In the 137 bypass grafts, 43 grafts were excluded in which postoperative ultrasound imaging within 1 month detected flow-limiting abnormalities. A total of 94 normal grafts were finally enrolled and randomly allotted to two groups: development data set for GF equation (74 grafts) and equation validation data set (20 grafts). Multivariate analysis with stepwise selection was performed to assess and detect factors associated with GF and to obtain GF predictive equation. Analyzed variables were sex, age, runoff, hemodialysis (HD), diabetes mellitus (DM), graft quality (GQ), hypertension, dyslipidemia, smoking history, inflow site, body mass index, cerebrovascular disease, ischemic cardiac disease, and foot infection. Runoff was evaluated with intraoperative angiography, and graded according to Rutherford runoff scoring system; then, the runoff score was classified into three groups: good, fair, or poor. The estimated equation was validated by Bland-Altman method and Student t-test. Actual GF was measured intraoperatively with transit time flowmeter.
Results: The GF determinant factors were runoff, HD, DM, and GQ: the most significant factors were runoff and HD (P < .0001). GF predictive equation was estimated as follows: GF (mL/min) ¼37.9 Â runoff þ 11.2 Â GQ e 15.1 Â DM e 38.5 Â HD + 7.1 (coefficient: runoff and GQ, good ¼ 3, fair ¼ 2, poor ¼ 1; DM and HD, yes ¼ 1, no ¼ 0). ( The Fig shows the Objectives: We describe a contemporary series of patients with acute limb ischemia (ALI) to identify factors that have an impact on limb salvage (LS) at a tertiary referral center for a large multistate geographic area.
Methods: A retrospective review of all patients with ALI secondary to thrombotic occlusion (TO) or embolic occlusion (EO) a single tertiary Results: A total of 112 patients with ALI were identified. The Table de scribes demographics, procedural data, and outcomes. Most patients were treated for TO (82%) and were transferred from an outside hospital (52% of TO, 74% of EO) with low transfer times (median, 1.9 hours for EO; median, 2.7 hours for TO). Median time to OR varied widely and was highest for TO patients and for patients with Rutherford class 1 or 3 disease. Median time to OR was 4 hours for Rutherford class 2a/2b patients. Occlusion was most commonly at the native femoral-popliteal level (44%) or due to an occluded bypass graft (25%). Primary amputation was performed in 9% of patients with TO; all of these had Rutherford class 3 ischemia. None of the patients with EO underwent primary amputation. LS rates were 91% for Rutherford class 1 and 2 patients and 15% for Rutherford class 3 patients. A total of 53% of EO patients and 24% of TO patients underwent fasciotomy, and 59% of fasciotomies were closed primarily. Multiple attempts at LS, higher Rutherford classification, nonviable muscle found at fasciotomy, and multilevel or aortoiliac levels of occlusion all predicted amputation (P < .05). Longer times to OR and transfer from an outside hospital showed clear trends toward higher amputation rates but did not reach statistical significance. The median LOS was 8 days with a median intensive care unit LOS of 2 days. A total of 32% of patients were discharged to a skilled nursing facility, and mortality was 5%.
Conclusions: LS was attainable in 91% of patients with Rutherford class 1 and 2 disease. Multiple attempts at LS, higher Rutherford class, and higher levels of occlusion all predicted amputation. Fasciotomy should not be withheld as it provides valuable information regarding LS and most wounds can be closed primarily. Transfer appears to be safe if performed in a timely fashion, most patients are discharged home, and deaths are rare.
Author Disclosures: S. Aarabi: Nothing to disclose; D. Emanuels: Nothing to disclose; E. Quiroga: Nothing to disclose; N. Singh: Nothing to disclose; B. W. Starnes: AORTICA Corporation: intellectual property/patents, ownership interest; N. Tran: Nothing to disclose. Objectives: Distal upper extremity vein bypass (dUEVB) is an infrequent procedure mainly performed for trauma, hemodialysis-associated pathologies, or chronic ischemia. There is little knowledge about the natural history of chronic ischemic disease of the upper extremity and only minimal knowledge about outcome of distal revascularization and limb salvage. Guidelines for the management of chronic ischemia of the upper extremity are missing. We have investigated the outcome of dUEVB for chronic ischemia.
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Distal Bypass for Chronic Limb-Threatening Ischemia of the Upper Extremity
Methods: This was a retrospective analysis of a consecutively collected case series in an academic tertiary referral setting. Standard statistical and reporting methods were used.
Results: A total of 209 bypass procedures in the upper extremity were collected from March 1996 to November 2016. Of these, 93 procedures in 78 patients (64 men [69.8%]) were performed for chronic ischemia and are the basis of this report. Median age was 55.5 (14.3-87.7) years. Vascular risk factors were nicotine use, 50 (53.8%); hypertension, 59 (64.5%); diabetes, 27 (29.0%); hyperlipidemia, 57 (61.3%); and renal failure, 23 (24.7%). Gangrene was present in 40 (43.0%). Underlying pathology: atherosclerotic, 42 (45.2%); chronic posttraumatic, 21 (22.6%); chronic postembolic, 13 (14.4%); thrombosed aneurysm/ hypothenar hammer, 8 (8.9%); Horton disease, 4 (4.4%); Buerger disease, 3 (3.3%); and Takayasu, 2 (2.2%). Distal target artery: brachial artery, 26 (27.9%); forearm arteries, 24 (25.8%); and distal to the wrist, 43 (46.2%). Vein grafts source: arm vein, 47 (50.5%); great saphenous, 37 (39.8%); and small saphenous, 9 (9.7%). Antithrombotic therapy:
antiaggregation, 49 (52.7%); anticoagulation, 13 (13.9%); and combination, 31 (33.3%). Five-year outcome: primary patency, 65%; limb salvage, 95%; and survival, 89%. Univariate analysis for adverse outcome: graft patency: female sex (P ¼ .001), diabetes (P ¼ .016), renal insufficiency (P ¼ .022); limb salvage: location of arterial occlusion (P ¼ .048); patient survival: diabetes (P ¼ .001), hypertension (P ¼ .029), and renal failure (P ¼ .0003). In multivariate analysis only renal failure was identified as an independent risk factor for inferior survival: hazard ratio, 8.28 (P ¼ .0023)
Conclusions: Indication for dUEVB for chronic ischemia is rare. Patients present with a wide variety of diseases for revascularization. Indication for surgery, graft choice, antithrombotic therapy, and outflow artery do not influence outcome. The only independent factor influencing survival is renal failure. dUEVB for chronic ischemia can be performed safely, and with excellent long-term results.
Author Disclosures: M. Aspalter: Nothing to disclose; J. Ellacuriaga San Martin: Nothing to disclose; F. Enzmann: Nothing to disclose; T. Hölzen-bein: Nothing to disclose; N. Hübl: Nothing to disclose; W. Hofmann: Nothing to disclose; K. Linni: Nothing to disclose; W. Hitzl: Nothing to disclose. Objectives: Unstable carotid stenosis is a major cause of stroke, but we lack methods to identify patients and lesions at risk. We recently described enrichment of molecular pathways associated with vascular calcification in carotid plaques from asymptomatic patients and from patients on statins. Here, we tested the hypothesis that calcification is a stabilizing feature in carotid atherosclerosis and examined whether calcification estimated by computed tomography (CT) can reflect plaque phenotype.
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Combination of Preoperative
Methods: Carotid endarterectomies from patients with symptomatic (S) and asymptomatic (AS) carotid stenosis were part of the Biobank of Karolinska Endarterectomies (BiKE). The calcification ratio was measured in preoperative CT angiographies using the plaque analysis application from the iNtuition software (TeraRecon), with threshold set to >400 HU. We used a discovery cohort with 19 high-calcified (18%-65%) and 21 low-calcified plaques (0%-9%) and a validation cohort of 127 plaques (87 S and 40 AS) and 10 normal arteries (NA). Plaques were profiled using Affymetrix microarrays and gene set enrichment and pathway mapping on differentially expressed genes. Results were adjusted for age, gender, and symptoms, corrected for multiple comparisons, and significance 
